Continuing our weekly clinical trial round-ups, here we look at developments in life sciences research and development announced during the week of 29th January to 2nd
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<